SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer
NCT03755115
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER_GOV
Sponsor class
Conditions
Small Cell Lung Cancer Extensive Stage
Interventions
DRUG:
Epirubicin plus SHR1210
Sponsor
Henan Cancer Hospital
Collaborators
[object Object]